Microbiology & Infectious Diseases

A newly developed DNA biochip offers a promising solution for the rapid screening of second-line drug resistance (SLDR) in Mycobacterium tuberculosis, offering faster detection and improved accuracy for multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB).

A groundbreaking dataset, the Antibiotic Resistance Microbiology Dataset (ARMD), has been developed to help combat antimicrobial resistance (AMR) by harnessing the power of electronic health records (EHRs).

Between November 2020 and June 2022, the United States conducted predeparture COVID-19 testing for nearly 24,000 refugees.

The growing body of research on the gut-skin axis and human microbiome has sparked increasing interest in microbiome-modulatory agents as potential treatments for acne vulgaris.

Healthcare provider support for Lyme disease vaccination has declined since 2018, raising concerns about rollout readiness as the first vaccine nears approval.

Anal cancer screening in people with HIV (PWH) is entering a new era, following major advances in evidence and recent guideline updates that aim to reduce cancer burden in this high-risk group.

A national survey of Canadian long-term care homes found that most facilities are actively monitoring healthcare-associated infections (HAIs), antimicrobial-resistant organisms (AROs), and antibiotic use, though the consistency and scope of these efforts vary.

High-quality clinical data is essential to maintaining trust in influenza vaccination programs, especially as the global death toll from seasonal flu approaches 700,000 annually, disproportionately affecting older adults.